Replies to post #330853 on Anavex Life Sciences Corp (AVXL)

[WolfofMia]

What we can see is that the $SAVA ADAS-Cog scores over time are all over the place with no clear trend based on longer dosing.

Hey what if we do one of these ;-)



Both companies definitely need to present more data, from a well designed trial.

Thankfully AVXL is at least 5 years ahead.

[Doc328]

The x axis is patient number not time

[Steady_T]

Those two sets of data are not even remotely comparable. The AVXL data is based on three different dosing levels. The SAVA data is based on one dosing level as I understand it.